580dbb0be5ddd4c2b3be84839dd33f2e

PAXMAN SCALP COOLING SYSTEM/ PAXMAN SISTEMA DE ENFRIAMIENTO DEL CUERO CABELLUDO / SISTEMA DE ENFRIAMIENTO DEL CUERO CABELLUDO

PAXMAN SCALP COOLING SYSTEM / PAXMAN SCALP COOLING SYSTEM / SCALP COOLING SYSTEM
REPRESENTACIONES OPTICAS COLOMBIANAS S.A - ROCOL S.A..·IIa·Colombia INVIMA·Expires June 29, 2032
Device classification
Risk class / Clase de Riesgo
IIa
Product type (Spanish)
MEDICO QUIRURGICOS
Product type (English)
SURGICAL DOCTOR
Registration information
Analysis ID
580dbb0be5ddd4c2b3be84839dd33f2e
Expire date
June 29, 2032
Authorized company / Fabricante
Name (English)
REPRESENTACIONES OPTICAS COLOMBIANAS S.A - ROCOL S.A..
Product use / Uso del Producto
Spanish

EL SISTEMA DE ENFRIAMIENTO DEL CUERO CABELLUDO PAXMAN, ESTÁ INDICADO PARA REDUCIR LA PÉRDIDA DE CABELLO INDUCIDA POR LA QUIMIOTERAPIA EN PACIENTES CON CÁNCER QUE RECIBEN QUIMIOTERAPIA SISTÉMICA CON AGENTES QUIMIOTERAPÉUTICOS QUE CAUSAN ALOPECIA.

English

THE PAXMAN SCALP COOLING SYSTEM IS INDICATED TO REDUCE CHEMOTHERAPY-INDUCED HAIR LOSS IN CANCER PATIENTS RECEIVING SYSTEMIC CHEMOTHERAPY WITH CHEMOTHERAPEUTIC AGENTS THAT CAUSE ALOPECIA.

About this record

Access comprehensive regulatory information for PAXMAN SCALP COOLING SYSTEM/ PAXMAN SISTEMA DE ENFRIAMIENTO DEL CUERO CABELLUDO / SISTEMA DE ENFRIAMIENTO DEL CUERO CABELLUDO (PAXMAN SCALP COOLING SYSTEM / PAXMAN SCALP COOLING SYSTEM / SCALP COOLING SYSTEM) in the Colombia medical device market through Pure Global AI's free database. This IIa medical device is registered under INVIMA analysis ID 580dbb0be5ddd4c2b3be84839dd33f2e and manufactured by REPRESENTACIONES OPTICAS COLOMBIANAS S.A - ROCOL S.A... The device was registered on June 29, 2032.

This page provides complete registration details including product type (SURGICAL DOCTOR), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.